Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Stockholders Equity of -$261.84 million for the year ending 2025.
- IRONWOOD PHARMACEUTICALS INC showed an increase of +13.1% in Stockholders Equity from 2024 to 2025.
- This data is from IRONWOOD PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $164.15 million | Q2 2012: $128.78 million | Q3 2012: $182.11 million | Q1 2013: $58.52 million | Q2 2013: $139.42 million | Q3 2013: $84.21 million | Q1 2014: $188.94 million | Q2 2014: $141.83 million | Q3 2014: $108.15 million | Q1 2015: $68.16 million | Q2 2015: $140.28 million | Q3 2015: $100.46 million | Q1 2016: $90.94 million | Q2 2016: $81.38 million | Q3 2016: $59.46 million | Q1 2017: $29.64 million | Q2 2017: $4.87 million | Q3 2017: -$17.58 million | Q1 2018: -$18.05 million | Q2 2018: -$43.95 million | Q3 2018: -$197.30 million | Q1 2019: -$237.18 million | Q2 2019: -$219.37 million | Q3 2019: -$153.05 million | Q1 2020: -$71.56 million | Q2 2020: -$36.85 million | Q3 2020: $5.90 million | Q4 2020: $62.64 million | Q1 2021: $110.19 million | Q2 2021: $511.76 million | Q3 2021: $579.94 million | Q1 2022: $517.78 million | Q2 2022: $532.88 million | Q3 2022: $591.06 million | Q1 2023: $706.85 million | Q2 2023: -$345.70 million | Q3 2023: -$323.22 million | Q1 2024: -$330.52 million | Q2 2024: -$321.73 million | Q3 2024: -$311.33 million | Q1 2025: -$334.05 million | Q2 2025: -$308.16 million | Q3 2025: -$264.16 million.
- Over the full 16 years of available data (2010 to 2025), IRONWOOD PHARMACEUTICALS INC's Stockholders Equity has declined by 264.1%.
- Historical annual values: Fiscal year 2025: -$261.84 million | Fiscal year 2024: -$301.34 million | Fiscal year 2023: -$346.30 million | Fiscal year 2022: $652.38 million | Fiscal year 2021: $605.91 million | Fiscal year 2020: $62.64 million | Fiscal year 2019: -$93.25 million | Fiscal year 2018: -$196.37 million | Fiscal year 2017: $9.85 million | Fiscal year 2016: $66.72 million | Fiscal year 2015: $95.13 million | Fiscal year 2014: $88.55 million | Fiscal year 2013: $38.23 million | Fiscal year 2012: $144.05 million | Fiscal year 2011: $109.86 million | Fiscal year 2010: $159.55 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: